ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global API Drug Development Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-22H17346
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global API Drug Development Service Market Research Report 2024
BUY CHAPTERS

Global API Drug Development Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-22H17346
Report
October 2025
Pages:149
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Carbogen-Amcis
Sterling Pharma Solutions
Cambrex
CordenPharma
Eurofins Scientific
Malvern Panalytical
ALMAC
Pfizer Inc
Axplora
Aptuit
Porton
Pharmaron Beijing
Shanghai Haoyuan Chemexpress
Stapharma

API Drug Development Service Market

The global API Drug Development Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Small Biotechs Companies accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
API Drug Development Service leading manufacturers including Lonza, Patheon, Catalent, Carbogen Amcis, Sterling Pharma Solutions, Cambrex, CordenPharma, Eurofins Scientific, Malvern Panalytical, Almac, etc., dominate supply; the top five capture approximately % of global revenue, with Lonza leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global API Drug Development Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of API Drug Development Service Market Report

Report Metric Details
Report Name API Drug Development Service Market
Segment by Type
  • Captive Product Development Service
  • Commercial Product Development Service
Segment by Application
  • Small Biotechs Companies
  • Large Pharmaceutical Organizations
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, Patheon, Catalent, Carbogen Amcis, Sterling Pharma Solutions, Cambrex, CordenPharma, Eurofins Scientific, Malvern Panalytical, Almac, Pfizer, Axplora, Aptuit, Porton, Pharmaron Beijing, Shanghai Haoyuan Chemexpress, Stapharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the API Drug Development Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the API Drug Development Service Market report?

Ans: The main players in the API Drug Development Service Market are Lonza, Patheon, Catalent, Carbogen Amcis, Sterling Pharma Solutions, Cambrex, CordenPharma, Eurofins Scientific, Malvern Panalytical, Almac, Pfizer, Axplora, Aptuit, Porton, Pharmaron Beijing, Shanghai Haoyuan Chemexpress, Stapharma

What are the Application segmentation covered in the API Drug Development Service Market report?

Ans: The Applications covered in the API Drug Development Service Market report are Small Biotechs Companies, Large Pharmaceutical Organizations

What are the Type segmentation covered in the API Drug Development Service Market report?

Ans: The Types covered in the API Drug Development Service Market report are Captive Product Development Service, Commercial Product Development Service

1 Study Coverage
1.1 Introduction to API Drug Development Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global API Drug Development Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Captive Product Development Service
1.2.3 Commercial Product Development Service
1.3 Market Segmentation by Application
1.3.1 Global API Drug Development Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Small Biotechs Companies
1.3.3 Large Pharmaceutical Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global API Drug Development Service Revenue Estimates and Forecasts 2020-2031
2.2 Global API Drug Development Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global API Drug Development Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global API Drug Development Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Captive Product Development Service Market Size by Players
3.3.2 Commercial Product Development Service Market Size by Players
3.4 Global API Drug Development Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global API Drug Development Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global API Drug Development Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America API Drug Development Service Market Size by Type (2020-2031)
6.4 North America API Drug Development Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America API Drug Development Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe API Drug Development Service Market Size by Type (2020-2031)
7.4 Europe API Drug Development Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe API Drug Development Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific API Drug Development Service Market Size by Type (2020-2031)
8.4 Asia-Pacific API Drug Development Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific API Drug Development Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America API Drug Development Service Market Size by Type (2020-2031)
9.4 Central and South America API Drug Development Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America API Drug Development Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa API Drug Development Service Market Size by Type (2020-2031)
10.4 Middle East and Africa API Drug Development Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa API Drug Development Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Business Overview
11.1.3 Lonza API Drug Development Service Product Features and Attributes
11.1.4 Lonza API Drug Development Service Revenue and Gross Margin (2020-2025)
11.1.5 Lonza API Drug Development Service Revenue by Product in 2024
11.1.6 Lonza API Drug Development Service Revenue by Application in 2024
11.1.7 Lonza API Drug Development Service Revenue by Geographic Area in 2024
11.1.8 Lonza API Drug Development Service SWOT Analysis
11.1.9 Lonza Recent Developments
11.2 Patheon
11.2.1 Patheon Corporation Information
11.2.2 Patheon Business Overview
11.2.3 Patheon API Drug Development Service Product Features and Attributes
11.2.4 Patheon API Drug Development Service Revenue and Gross Margin (2020-2025)
11.2.5 Patheon API Drug Development Service Revenue by Product in 2024
11.2.6 Patheon API Drug Development Service Revenue by Application in 2024
11.2.7 Patheon API Drug Development Service Revenue by Geographic Area in 2024
11.2.8 Patheon API Drug Development Service SWOT Analysis
11.2.9 Patheon Recent Developments
11.3 Catalent
11.3.1 Catalent Corporation Information
11.3.2 Catalent Business Overview
11.3.3 Catalent API Drug Development Service Product Features and Attributes
11.3.4 Catalent API Drug Development Service Revenue and Gross Margin (2020-2025)
11.3.5 Catalent API Drug Development Service Revenue by Product in 2024
11.3.6 Catalent API Drug Development Service Revenue by Application in 2024
11.3.7 Catalent API Drug Development Service Revenue by Geographic Area in 2024
11.3.8 Catalent API Drug Development Service SWOT Analysis
11.3.9 Catalent Recent Developments
11.4 Carbogen Amcis
11.4.1 Carbogen Amcis Corporation Information
11.4.2 Carbogen Amcis Business Overview
11.4.3 Carbogen Amcis API Drug Development Service Product Features and Attributes
11.4.4 Carbogen Amcis API Drug Development Service Revenue and Gross Margin (2020-2025)
11.4.5 Carbogen Amcis API Drug Development Service Revenue by Product in 2024
11.4.6 Carbogen Amcis API Drug Development Service Revenue by Application in 2024
11.4.7 Carbogen Amcis API Drug Development Service Revenue by Geographic Area in 2024
11.4.8 Carbogen Amcis API Drug Development Service SWOT Analysis
11.4.9 Carbogen Amcis Recent Developments
11.5 Sterling Pharma Solutions
11.5.1 Sterling Pharma Solutions Corporation Information
11.5.2 Sterling Pharma Solutions Business Overview
11.5.3 Sterling Pharma Solutions API Drug Development Service Product Features and Attributes
11.5.4 Sterling Pharma Solutions API Drug Development Service Revenue and Gross Margin (2020-2025)
11.5.5 Sterling Pharma Solutions API Drug Development Service Revenue by Product in 2024
11.5.6 Sterling Pharma Solutions API Drug Development Service Revenue by Application in 2024
11.5.7 Sterling Pharma Solutions API Drug Development Service Revenue by Geographic Area in 2024
11.5.8 Sterling Pharma Solutions API Drug Development Service SWOT Analysis
11.5.9 Sterling Pharma Solutions Recent Developments
11.6 Cambrex
11.6.1 Cambrex Corporation Information
11.6.2 Cambrex Business Overview
11.6.3 Cambrex API Drug Development Service Product Features and Attributes
11.6.4 Cambrex API Drug Development Service Revenue and Gross Margin (2020-2025)
11.6.5 Cambrex Recent Developments
11.7 CordenPharma
11.7.1 CordenPharma Corporation Information
11.7.2 CordenPharma Business Overview
11.7.3 CordenPharma API Drug Development Service Product Features and Attributes
11.7.4 CordenPharma API Drug Development Service Revenue and Gross Margin (2020-2025)
11.7.5 CordenPharma Recent Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Corporation Information
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific API Drug Development Service Product Features and Attributes
11.8.4 Eurofins Scientific API Drug Development Service Revenue and Gross Margin (2020-2025)
11.8.5 Eurofins Scientific Recent Developments
11.9 Malvern Panalytical
11.9.1 Malvern Panalytical Corporation Information
11.9.2 Malvern Panalytical Business Overview
11.9.3 Malvern Panalytical API Drug Development Service Product Features and Attributes
11.9.4 Malvern Panalytical API Drug Development Service Revenue and Gross Margin (2020-2025)
11.9.5 Malvern Panalytical Recent Developments
11.10 Almac
11.10.1 Almac Corporation Information
11.10.2 Almac Business Overview
11.10.3 Almac API Drug Development Service Product Features and Attributes
11.10.4 Almac API Drug Development Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Pfizer
11.11.1 Pfizer Corporation Information
11.11.2 Pfizer Business Overview
11.11.3 Pfizer API Drug Development Service Product Features and Attributes
11.11.4 Pfizer API Drug Development Service Revenue and Gross Margin (2020-2025)
11.11.5 Pfizer Recent Developments
11.12 Axplora
11.12.1 Axplora Corporation Information
11.12.2 Axplora Business Overview
11.12.3 Axplora API Drug Development Service Product Features and Attributes
11.12.4 Axplora API Drug Development Service Revenue and Gross Margin (2020-2025)
11.12.5 Axplora Recent Developments
11.13 Aptuit
11.13.1 Aptuit Corporation Information
11.13.2 Aptuit Business Overview
11.13.3 Aptuit API Drug Development Service Product Features and Attributes
11.13.4 Aptuit API Drug Development Service Revenue and Gross Margin (2020-2025)
11.13.5 Aptuit Recent Developments
11.14 Porton
11.14.1 Porton Corporation Information
11.14.2 Porton Business Overview
11.14.3 Porton API Drug Development Service Product Features and Attributes
11.14.4 Porton API Drug Development Service Revenue and Gross Margin (2020-2025)
11.14.5 Porton Recent Developments
11.15 Pharmaron Beijing
11.15.1 Pharmaron Beijing Corporation Information
11.15.2 Pharmaron Beijing Business Overview
11.15.3 Pharmaron Beijing API Drug Development Service Product Features and Attributes
11.15.4 Pharmaron Beijing API Drug Development Service Revenue and Gross Margin (2020-2025)
11.15.5 Pharmaron Beijing Recent Developments
11.16 Shanghai Haoyuan Chemexpress
11.16.1 Shanghai Haoyuan Chemexpress Corporation Information
11.16.2 Shanghai Haoyuan Chemexpress Business Overview
11.16.3 Shanghai Haoyuan Chemexpress API Drug Development Service Product Features and Attributes
11.16.4 Shanghai Haoyuan Chemexpress API Drug Development Service Revenue and Gross Margin (2020-2025)
11.16.5 Shanghai Haoyuan Chemexpress Recent Developments
11.17 Stapharma
11.17.1 Stapharma Corporation Information
11.17.2 Stapharma Business Overview
11.17.3 Stapharma API Drug Development Service Product Features and Attributes
11.17.4 Stapharma API Drug Development Service Revenue and Gross Margin (2020-2025)
11.17.5 Stapharma Recent Developments
12 API Drug Development ServiceIndustry Chain Analysis
12.1 API Drug Development Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 API Drug Development Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global API Drug Development Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Carbogen-Amcis
Sterling Pharma Solutions
Cambrex
CordenPharma
Eurofins Scientific
Malvern Panalytical
ALMAC
Pfizer Inc
Axplora
Aptuit
Porton
Pharmaron Beijing
Shanghai Haoyuan Chemexpress
Stapharma
List of Tables
 Table 1. Global API Drug Development Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global API Drug Development Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global API Drug Development Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global API Drug Development Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global API Drug Development Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global API Drug Development Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global API Drug Development Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global API Drug Development Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in API Drug Development Service as of 2024)
 Table 11. Global API Drug Development Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global API Drug Development Service Companies Headquarters
 Table 13. Global API Drug Development Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global API Drug Development Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global API Drug Development Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global API Drug Development Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global API Drug Development Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. API Drug Development Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America API Drug Development Service Growth Accelerators and Market Barriers
 Table 25. North America API Drug Development Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe API Drug Development Service Growth Accelerators and Market Barriers
 Table 27. Europe API Drug Development Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific API Drug Development Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific API Drug Development Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America API Drug Development Service Investment Opportunities and Key Challenges
 Table 31. Central and South America API Drug Development Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa API Drug Development Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa API Drug Development Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Lonza Corporation Information
 Table 35. Lonza Description and Major Businesses
 Table 36. Lonza Product Features and Attributes
 Table 37. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Lonza Revenue Proportion by Product in 2024
 Table 39. Lonza Revenue Proportion by Application in 2024
 Table 40. Lonza Revenue Proportion by Geographic Area in 2024
 Table 41. Lonza API Drug Development Service SWOT Analysis
 Table 42. Lonza Recent Developments
 Table 43. Patheon Corporation Information
 Table 44. Patheon Description and Major Businesses
 Table 45. Patheon Product Features and Attributes
 Table 46. Patheon Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Patheon Revenue Proportion by Product in 2024
 Table 48. Patheon Revenue Proportion by Application in 2024
 Table 49. Patheon Revenue Proportion by Geographic Area in 2024
 Table 50. Patheon API Drug Development Service SWOT Analysis
 Table 51. Patheon Recent Developments
 Table 52. Catalent Corporation Information
 Table 53. Catalent Description and Major Businesses
 Table 54. Catalent Product Features and Attributes
 Table 55. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Catalent Revenue Proportion by Product in 2024
 Table 57. Catalent Revenue Proportion by Application in 2024
 Table 58. Catalent Revenue Proportion by Geographic Area in 2024
 Table 59. Catalent API Drug Development Service SWOT Analysis
 Table 60. Catalent Recent Developments
 Table 61. Carbogen Amcis Corporation Information
 Table 62. Carbogen Amcis Description and Major Businesses
 Table 63. Carbogen Amcis Product Features and Attributes
 Table 64. Carbogen Amcis Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Carbogen Amcis Revenue Proportion by Product in 2024
 Table 66. Carbogen Amcis Revenue Proportion by Application in 2024
 Table 67. Carbogen Amcis Revenue Proportion by Geographic Area in 2024
 Table 68. Carbogen Amcis API Drug Development Service SWOT Analysis
 Table 69. Carbogen Amcis Recent Developments
 Table 70. Sterling Pharma Solutions Corporation Information
 Table 71. Sterling Pharma Solutions Description and Major Businesses
 Table 72. Sterling Pharma Solutions Product Features and Attributes
 Table 73. Sterling Pharma Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Sterling Pharma Solutions Revenue Proportion by Product in 2024
 Table 75. Sterling Pharma Solutions Revenue Proportion by Application in 2024
 Table 76. Sterling Pharma Solutions Revenue Proportion by Geographic Area in 2024
 Table 77. Sterling Pharma Solutions API Drug Development Service SWOT Analysis
 Table 78. Sterling Pharma Solutions Recent Developments
 Table 79. Cambrex Corporation Information
 Table 80. Cambrex Description and Major Businesses
 Table 81. Cambrex Product Features and Attributes
 Table 82. Cambrex Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Cambrex Recent Developments
 Table 84. CordenPharma Corporation Information
 Table 85. CordenPharma Description and Major Businesses
 Table 86. CordenPharma Product Features and Attributes
 Table 87. CordenPharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. CordenPharma Recent Developments
 Table 89. Eurofins Scientific Corporation Information
 Table 90. Eurofins Scientific Description and Major Businesses
 Table 91. Eurofins Scientific Product Features and Attributes
 Table 92. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Eurofins Scientific Recent Developments
 Table 94. Malvern Panalytical Corporation Information
 Table 95. Malvern Panalytical Description and Major Businesses
 Table 96. Malvern Panalytical Product Features and Attributes
 Table 97. Malvern Panalytical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Malvern Panalytical Recent Developments
 Table 99. Almac Corporation Information
 Table 100. Almac Description and Major Businesses
 Table 101. Almac Product Features and Attributes
 Table 102. Almac Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Almac Recent Developments
 Table 104. Pfizer Corporation Information
 Table 105. Pfizer Description and Major Businesses
 Table 106. Pfizer Product Features and Attributes
 Table 107. Pfizer Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Pfizer Recent Developments
 Table 109. Axplora Corporation Information
 Table 110. Axplora Description and Major Businesses
 Table 111. Axplora Product Features and Attributes
 Table 112. Axplora Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Axplora Recent Developments
 Table 114. Aptuit Corporation Information
 Table 115. Aptuit Description and Major Businesses
 Table 116. Aptuit Product Features and Attributes
 Table 117. Aptuit Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Aptuit Recent Developments
 Table 119. Porton Corporation Information
 Table 120. Porton Description and Major Businesses
 Table 121. Porton Product Features and Attributes
 Table 122. Porton Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Porton Recent Developments
 Table 124. Pharmaron Beijing Corporation Information
 Table 125. Pharmaron Beijing Description and Major Businesses
 Table 126. Pharmaron Beijing Product Features and Attributes
 Table 127. Pharmaron Beijing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Pharmaron Beijing Recent Developments
 Table 129. Shanghai Haoyuan Chemexpress Corporation Information
 Table 130. Shanghai Haoyuan Chemexpress Description and Major Businesses
 Table 131. Shanghai Haoyuan Chemexpress Product Features and Attributes
 Table 132. Shanghai Haoyuan Chemexpress Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Shanghai Haoyuan Chemexpress Recent Developments
 Table 134. Stapharma Corporation Information
 Table 135. Stapharma Description and Major Businesses
 Table 136. Stapharma Product Features and Attributes
 Table 137. Stapharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Stapharma Recent Developments
 Table 139. Raw Materials Key Suppliers
 Table 140. Distributors List
 Table 141. Market Trends and Market Evolution
 Table 142. Market Drivers and Opportunities
 Table 143. Market Challenges, Risks, and Restraints
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources


List of Figures
 Figure 1. API Drug Development Service Product Picture
 Figure 2. Global API Drug Development Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Captive Product Development Service Product Picture
 Figure 4. Commercial Product Development Service Product Picture
 Figure 5. Global API Drug Development Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Small Biotechs Companies
 Figure 7. Large Pharmaceutical Organizations
 Figure 8. API Drug Development Service Report Years Considered
 Figure 9. Global API Drug Development Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 11. Global API Drug Development Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global API Drug Development Service Revenue Market Share by Region (2020-2031)
 Figure 13. Global API Drug Development Service Revenue Market Share Ranking (2024)
 Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 15. Captive Product Development Service Revenue Market Share by Player in 2024
 Figure 16. Commercial Product Development Service Revenue Market Share by Player in 2024
 Figure 17. Global API Drug Development Service Revenue Market Share by Type (2020-2031)
 Figure 18. Global API Drug Development Service Revenue Market Share by Application (2020-2031)
 Figure 19. North America API Drug Development Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 20. North America Top 5 Players API Drug Development Service Revenue (US$ Million) in 2024
 Figure 21. North America API Drug Development Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 22. North America API Drug Development Service Revenue (US$ Million) by Application (2020-2031)
 Figure 23. US API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 24. Canada API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 25. Mexico API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 26. Europe API Drug Development Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Europe Top 5 Players API Drug Development Service Revenue (US$ Million) in 2024
 Figure 28. Europe API Drug Development Service Revenue (US$ Million) by Type (2020-2031)
 Figure 29. Europe API Drug Development Service Revenue (US$ Million) by Application (2020-2031)
 Figure 30. Germany API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 31. France API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 32. U.K. API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 33. Italy API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 34. Russia API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific API Drug Development Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Top 8 Players API Drug Development Service Revenue (US$ Million) in 2024
 Figure 37. Asia-Pacific API Drug Development Service Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Asia-Pacific API Drug Development Service Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Indonesia API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 40. Japan API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 41. South Korea API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 42. Australia API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 43. India API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 44. Indonesia API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 45. Vietnam API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 46. Malaysia API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 47. Philippines API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 48. Singapore API Drug Development Service Revenue (2020-2031) & (US$ Million)
 Figure 49. Central and South America API Drug Development Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Central and South America Top 5 Players API Drug Development Service Revenue (US$ Million) in 2024
 Figure 51. Central and South America API Drug Development Service Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Central and South America API Drug Development Service Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Brazil API Drug Development Service Revenue (2020-2025) & (US$ Million)
 Figure 54. Argentina API Drug Development Service Revenue (2020-2025) & (US$ Million)
 Figure 55. Middle East and Africa API Drug Development Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Top 5 Players API Drug Development Service Revenue (US$ Million) in 2024
 Figure 57. South America API Drug Development Service Revenue (US$ Million) by Type (2020-2031)
 Figure 58. Middle East and Africa API Drug Development Service Revenue (US$ Million) by Application (2020-2031)
 Figure 59. GCC Countries API Drug Development Service Revenue (2020-2025) & (US$ Million)
 Figure 60. Israel API Drug Development Service Revenue (2020-2025) & (US$ Million)
 Figure 61. Egypt API Drug Development Service Revenue (2020-2025) & (US$ Million)
 Figure 62. South Africa API Drug Development Service Revenue (2020-2025) & (US$ Million)
 Figure 63. API Drug Development Service Industry Chain Mapping
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global API Development Tools Market Research Report 2024
Global API Process Development Market Research Report 2025
Api Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Custom API Development Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Discovery and Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Molecule API Development Service Market Research Report 2025
Global API Management Services Market Research Report 2024
Global Enalapril API Market Research Report 2024
Global API Design Tools Market Research Report 2024
Global API Managed Service Market Research Report 2025
Global API Data Interface Service Market Research Report 2024
Global API Testing Tool Market Research Report 2025
Global Generic API Market Research Report 2025
Global API Process Development and Manufacturing Market Research Report 2025
Global Sildenafil API Market Research Report 2024
Global Open API Market Research Report 2024
Global Communication API Market Research Report 2024
Global SAP Development Service Market Research Report 2024
Global Flurbiprofen API Market Research Report 2025
Global Formulation Development Service Market Research Report 2025

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions